Condition: Lung Cancer · Breast Cancer · Sponsor: Bristol-Myers Squibb
The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary efficacy of BMS-986507 combinations in adult participants with advanced solid tumors.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| University of Miami Hospital and Clinics, Sylvester Cancer Center | Miami, Florida, United States | Recruiting |
| Local Institution - 0065 | Iowa City, Iowa, United States | Not Yet Recruiting |
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Recruiting |
| Local Institution - 0102 | Columbus, Ohio, United States | Not Yet Recruiting |
| Providence Portland Medical Center | Portland, Oregon, United States | Recruiting |
| Providence St. Vincent Medical Center | Portland, Oregon, United States | Recruiting |
| Local Institution - 0052 | Portland, Oregon, United States | Not Yet Recruiting |
| Local Institution - 0014 | Pittsburgh, Pennsylvania, United States | Withdrawn |
| University of Tennessee Medical Center | Knoxville, Tennessee, United States | Recruiting |
| NEXT Oncology - Irving | Irving, Texas, United States | Recruiting |
+ 49 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06618287